Prednisolone and Concomitant disease aggravated - a phase IV clinical study of FDA data
Concomitant disease aggravated is found among people who take Prednisolone, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Prednisolone and have Concomitant disease aggravated. It is created by eHealthMe based on reports of 180,802 people who have side effects when taking Prednisolone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
180,802 people reported to have side effects when taking Prednisolone.
Among them, 219 people (0.12%) have Concomitant disease aggravated.
What is Prednisolone?
Prednisolone has active ingredients of prednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 182,024 Prednisolone users for its effectiveness, alternative drugs and more.
What is Concomitant disease aggravated?
Concomitant disease aggravated (advanced due to some of accompanying) is found to be associated with 778 drugs and 562 conditions by eHealthMe.
Number of Prednisolone and Concomitant disease aggravated reports submitted per year:
Time on Prednisolone when people have Concomitant disease aggravated *:
Gender of people who have Concomitant disease aggravated when taking Prednisolone*:
Age of people who have Concomitant disease aggravated when taking Prednisolone *:
Common drugs people take besides Prednisolone *:
Common side effects people have besides Concomitant disease aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Prednisolone and have Concomitant disease aggravated?Check whether Concomitant disease aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Abdullah, D., Mohamed, A. M. F. S., & Liew, A. K. C., "Dentine hypersensitivity-like tooth pain associated with the use of high-dose steroid therapy", Journal of conservative dentistry: JCD, 2018 Jan .
How severe was Concomitant disease aggravated and when was it recovered:
Expand to all the drugs that have ingredients of prednisolone:
Alternative drugs to, pros and cons of Prednisolone:
- Prednisolone (182,024 reports)
Common Prednisolone side effects:
Browse all side effects of Prednisolone:a b c d e f g h i j k l m n o p q r s t u v w x y z
Concomitant disease aggravated treatments and more:
- Concomitant disease aggravated (7,072 reports)
COVID vaccines that are related to Concomitant disease aggravated:
- Concomitant disease aggravated in Moderna COVID Vaccine
- Concomitant disease aggravated in Pfizer BioNTech Covid Vaccine
- Concomitant disease aggravated in Johnson and Johnson Covid Vaccine
Common drugs associated with Concomitant disease aggravated:
All the drugs that are associated with Concomitant disease aggravated:
- Concomitant disease aggravated (778 drugs)
Common conditions associated with Concomitant disease aggravated:
All the conditions that are associated with Concomitant disease aggravated:
- Concomitant disease aggravated (562 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on prednisolone (the active ingredients of Prednisolone) and Prednisolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vyvanse vs. Aplenzin - a second ago
- Insulin and Injection Site Induration - 11 seconds ago
- Duspatal and Exjade drug interaction - 19 seconds ago
- Pamelor and Midodrine Hydrochloride drug interaction - 20 seconds ago
- Hypothyroidism and Clostridium Difficile Colitis - 27 seconds ago
- Coumadin and Forearm Fracture - 27 seconds ago
- Anaemia and Leukopenia - 31 seconds ago
- Motrin Ib and Vicoprofen drug interaction - 36 seconds ago
- Rozerem and Taste - Impaired - 37 seconds ago
- Bladder Disorder and Osteopenia - 38 seconds ago